tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Purkiss, 16 are a BUY (80%), 4 are a HOLD (20%).
Analyst Richard Purkiss, currently employed at JPMORGAN, carries an average stock price target met ratio of 90% that have a potential upside of 69.16% achieved within 1163 days.
Richard Purkiss’s has documented 41 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 25-Feb-2020.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 2/25/2020. The price target of $107 was fulfilled within 143 days with a profit of $26.17 (32.38%) receiving and performance score of 2.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Jul-2019
$26
$1.83 (7.57%)
$26
6 days ago
(10-Jul-2026)
5/7 (71.43%)
$1.83 (7.57%)
581
0.56
Hold Since 01-Jun-2020
$28
$3.83 (15.85%)
$30
8 days ago
(08-Jul-2026)
9/18 (50%)
$3.95 (16.42%)
1020
0.55
Buy Since 17-Mar-2026
$28
$3.83 (15.85%)
$32
10 days ago
(06-Jul-2026)
0/3 (0%)
$4.28 (18.04%)
0
Hold Since 26-Feb-2020
$27
$2.83 (11.71%)
$27
10 days ago
(06-Jul-2026)
13/24 (54.17%)
$3.28 (13.83%)
149
1.16
Sell Since 25-Feb-2026
$25
$0.71 (2.92%)
$25
1 months 6 days ago
(10-Jun-2026)
4/9 (44.44%)
$-0.6 (-2.34%)
78
0.53
What Year was the first public recommendation made by Richard Purkiss?
